Safety, efficacy and costs of pharmacotherapy for functional gastrointestinal disorders: the case of alosetron and its implications.
about
CD4+ T cell-mediated immunological control of enterochromaffin cell hyperplasia and 5-hydroxytryptamine production in enteric infection.Serotonin and GI Disorders: An Update on Clinical and Experimental Studies.Gut hormones: emerging role in immune activation and inflammation.Alosetron and irritable bowel syndrome.Subjective food hypersensitivity: assessment of enterochromaffin cell markers in blood and gut lavage fluid.Rotavirus vaccine RIX4414 (Rotarix™): a pharmacoeconomic review of its use in the prevention of rotavirus gastroenteritis in developing countries.The chronic gastrointestinal consequences associated with campylobacter.5-HT7 receptor signaling: improved therapeutic strategy in gut disordersQuantitative benefit-risk assessment using only qualitative information on utilities.
P2860
Q33274027-6EC67FBA-C47D-440D-9D97-DFF49138C95CQ34317503-8BCE1077-2C29-4C8A-B53A-091CCAEE1889Q34618925-C6C332CD-7BAC-4710-BFAF-9967E0DE0B03Q34649076-70FCAEF7-11AC-4031-917C-5C2B9C5F1849Q35178813-B27909CB-F72E-4F6A-BDDE-F583AFA64B28Q37944318-5873972F-301F-4948-ABD9-280128DC5005Q38032174-397101A8-31E9-4A74-A006-A349B45D493CQ38310117-6AEB3D5D-CD12-4D00-8E8F-64853802CF64Q45138901-0562FF6C-CC51-4F1F-BAB3-9FFF92165192
P2860
Safety, efficacy and costs of pharmacotherapy for functional gastrointestinal disorders: the case of alosetron and its implications.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Safety, efficacy and costs of ...... losetron and its implications.
@en
Safety, efficacy and costs of ...... losetron and its implications.
@nl
type
label
Safety, efficacy and costs of ...... losetron and its implications.
@en
Safety, efficacy and costs of ...... losetron and its implications.
@nl
prefLabel
Safety, efficacy and costs of ...... losetron and its implications.
@en
Safety, efficacy and costs of ...... losetron and its implications.
@nl
P2860
P1476
Safety, efficacy and costs of ...... losetron and its implications.
@en
P2093
Ladabaum U
P2860
P304
P356
10.1046/J.1365-2036.2003.01545.X
P407
P577
2003-04-01T00:00:00Z